盐酸克伦特罗在玻碳电极上的伏安行为研究

采用电化学技术研究了盐酸克伦特罗(CLB)在玻碳电极上的电化学还原行为。在pH4.54的Britton Robinson缓冲液中,CLB于 0.38V(vs.Ag AgCl)左右处出现一个明显的方波溶出伏安还原峰,峰电流与CLB的浓度在3.0×10-7～1.0×10-5mol L范围内呈良好的线性关系,检出限为5.1×10-8mol L。该法可应用于模拟兔血清及尿样中CLB的测定。     

Antibodies conjugated with new highly luminescent Eu and Tb chelates as markers for time resolved immunoassays. Application to simultaneous determination of clenbuterol and free cortisol in horse urine

Highly luminescent Eu³⁺ and Tb³⁺ complexes of 10-[4-(3-isothiocyanatopropoxy)benzoylmethyl]-1,4,7,10-tetraazacyclododecane-1,4,7 triacetic acid Eu³⁺ ⊂ 1 and Tb³⁺ ⊂ 1 were conjugated with a goat anti-rabbit IgG and a rabbit anti-mouse IgG, respectively, and applied as markers in a time resolved immunoassay for simultaneous quantitative determination of anabolic compounds clenbuterol (CL) and hydrocortisone (HC). The assay was performed in horse urine, using a monoclonal antibody specific to CL and a rabbit polyclonal antibody specific to the free HC. These lanthanide chelates are very stable and highly luminescent in aqueous solution and allowed to reach 10 μg L⁻¹ and 40 μg L⁻¹ sensitivities for CL and for HC, respectively. Application to the horse urine, that is a very complex matrix, has a considerable interest in the control of illegal use of these compounds.     

猪肝中克伦特罗和沙丁胺醇的毛细管电泳-质谱联用分析

盐酸克仑特罗和沙丁胺醇等均属激动剂类药物,人体的累计摄入量超过一定值或食用了高残留的内脏组织,易出现毒副作用[1],因此许多国家都将其列为违禁药物。近年来一些不法饲养业主受利益驱使,将沙丁胺醇(salbutamol)作为“瘦肉精”的替代品在生猪养殖中非法使用。关于克伦特罗和     

毛细管电泳电化学法分离检测盐酸克伦特罗、特布他林和沙丁胺醇

建立了毛细管电泳电化学法对盐酸克伦特罗、特布他林和沙丁胺醇进行分离检测。方法采用胶束电泳体系,以铂圆盘为工作电极,考察了检测电位、缓冲液浓度和pH、十二烷基硫酸钠(SDS)浓度、分离电压等因素的影响。3个分离物在10 kV的分离电压、缓冲体系为15 mmol/L(pH 9.0)硼砂+20 mmol/L SDS条件下得到分离。盐酸克伦特罗、特布他林和沙丁胺醇的线性范围分别为2.0～400,3.5～700,5.0～1000μg/L。方法已用于猪肉样品的检测。     

荧光光谱法研究克仑特罗与蛋白质的结合作用

应用荧光光谱法研究了水溶液中盐酸克仑特罗与牛血清白蛋白分子间的结合反应 ,测定了结合常数 (K =2 .84× 1 0 3 L mol)和结合位点数 (n =5 .65)。依据F ster非辐射能量转移理论 ,确定了授体 受体间的结合距离 (r=1 .69nm)和能量转移效率 ,采用同步荧光技术考察了盐酸克仑特罗对牛血清白蛋白构象的影响。利用盐酸克仑特罗对蛋白质荧光猝灭 ,对作用机理做了初步探讨     

A straightforward route to obtain C1-labeled clenbuterol

Singly-labeled ¹³C₁-clenbuterol has been synthesized employing a straightforward pathway starting from easily available acetanilide. The critical step was the Friedel-Crafts acylation of this compound with marked acetyl chloride, being the first example of the use of this methodology applied to the synthesis of a clenbuterol derivative. Subsequent chemical reactions afforded the desired product with good yields.     

Determination of clenbuterol in pig liver by high-performance liquid chromatography with a coulometric electrode array system

A method has been developed to determine clenbuterol in pig liver using HPLC with coulometric electrode array system, for this compound can be irreversibly oxidized at high potentials by ordinary methods. Investigation into the effect of the pH of mobile phase on the retention factor and peak height of clenbuterol was made. The electrochemical behavior of clenbuterol at graphite electrodes was taken into account. Optimization of different extract conditions was also performed. The samples were pretreated using liquid-liquid extraction based on diethyl ether and the organic layer was evaporated to dryness. The residue was dissolved in mobile phase and monitored by an ESA electrochemical detector. Four electrodes in series were used for quantitation and the potentials of electrodes were set at 450, 600, 650 and 680 mV, respectively. Calibration curve showed good linearity and the detection limit of clenbuterol was 1.2 ng/g. This method developed using HPLC-ECD is reproducible, and sensitive enough for the determination of clenbuterol in pig liver. It is easy to perform.     

Production of “in house” reference materials for ELISA screening of bovine urine and liver samples for clenbuterol

Clenbuterol screening of bovines is done by analysis of urine, for monitoring living animals, and liver, for monitoring animals after slaughter. ELISA has generally been used as the main method for these purposes. Nevertheless, in Europe, methods must be validated according to Commission Decision (EC) 657/2007 criteria, i.e. by use of reference materials. Production of “in house” reference materials is a possibility, but the homogeneity, storage temperature, and period of stability of these materials must be investigated in the laboratory itself. This paper reports GC–MS evaluation of an “in-house”-produced batch of aliquots of bovine urine and liver, fortified with 10.0 ng/ml and 10.0 ng/g clenbuterol, respectively, and stored at ?20 °C and at ?60 °C. For urine stored for 20 weeks at ?20 °C and at 60 °C the stability of clenbuterol was proved at the 95% confidence level. For liver, however, it was demonstrated at the same confidence level that clenbuterol was highly unstable during storage for 20 weeks at either of the temperatures studied.     

Determination of clenbuterol by capillary electrophoresis immunoassay with chemiluminescence detection

A competitive immunoassay for clenbuterol (CLB) based on capillary electrophoresis with chemiluminescence (CL) detection was established. The method was based on the competitive reaction of horseradish peroxidase (HRP)-labeled CLB (CLB-HRP) and free CLB with anti-CLB antiserum. The factors affecting the electrophoresis and CL detection were systematically investigated with HRP as a model sample. Under the optimal conditions, the tracer CLB-HRP and the immunoassay complex were separated, and the linear range and the detection limit (S/N = 3) for CLB were 5.0-40 nmol l⁻¹ and 1.2 nmol l⁻¹, respectively. The proposed method has been applied satisfactorily in the analysis of urine sample.     

Analysis of β-agonists and β-blockers in urine using hollow fibre-protected liquid-phase microextraction with in situ derivatization followed by gas chromatography/mass spectrometry

A method using hollow fibre-protected liquid-phase microextraction (HF-LPME) with in situ derivatization followed by gas chromatography/mass spectrometry (GC/MS) was established for the analysis of β-agonists and β-blockers in urine. Because it can simultaneously extract and derivatize compounds of interest by methylbenzol and N-methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA) in HF-LPME, the approach overcomes the drawbacks of considerable time-consuming and tedious operation, meanwhile improves enrichment multiple. The optimized conditions were extraction for 20 min at 35 °C with 5.0 μL of mixed extraction solvent (methylbenzol/MSTFA = 1:1, v/v) with stirring speed of 925 rpm in 5.0 mL sample under pH 12.0 and 14% (w/v) NaCl. The method provided very wide linear ranges (0.25–400 ng mL⁻¹) and low detection limits in the range of 0.08–0.10 ng mL⁻¹ for clenbuterol, metoprolol and propranolol while enrichment factors reached up to 256. The analytes could be determined in spiked urine by the method with high extraction efficacy (93.79–109.04% recoveries) and precision (<9.70% RSD). It has a satisfactory result for metoprolol in practical human urine samples for a single-dose administration of 50 mg after 36 h. The proposed method only needs few microliters of organic solvent and derivatizing agent; the operation is simple, convenient and rapid for the trace analysis of β-agonists and β-blockers in biological fluids; it can be readily generalized for high sample throughput. So, it is hopeful that the study will facilitate the monitoring of β-agonists and β-blockers in the competition sports.